Since, Bmal1 and Gata4 affect both lipoprotein production and cholesterol secretion to bile, it is likely that their higher efficacy in reducing atherosclerosis compared with Shp is secondary to their effects on both these processes. Here, BMAL1 is linked to atherosclerosis.